SYVN1 and prostate carcinoma: Our data revealed that gp78, Hrd1, SVIP and AR showed increased expression (p < 0.05 for AR and p < 0.005 for gp78, Hrd1, SVIP) in prostate cancer tissues (Fig. 6A).